Biotoscana

Biotoscana, established in 1984, is a specialized medical research company dedicated to addressing critical unmet needs for patients suffering from rare and severe health conditions. The company focuses on developing and distributing life-saving medications, particularly for challenging therapeutic areas such as pulmonary hypertension and rare metabolic disorders. By collaborating closely with leading global pharmaceutical partners, Biotoscana ensures access to innovative treatments across Latin America. Its commitment lies in advancing patient care through scientific rigor and strategic alliances within the healthcare sector.

Operating with a dedicated team of 500-1,000 employees, Biotoscana maintains significant operations across Argentina, Chile, Ecuador, and Peru, serving the broader Latin American market. The company's strategic focus on specialized pharmaceuticals positions it as a key player in its operational regions. Meet Biotoscana's team to understand the expertise driving its mission. This extensive network and operational capacity enable Biotoscana to effectively deliver critical therapies to patient populations that often have limited treatment options.

As a prominent entity within the Pharmaceuticals and Healthcare industries, Biotoscana leverages its deep scientific understanding and market presence to impact patient outcomes positively. Its business model is built on identifying and commercializing advanced therapies, contributing to improved public health across the regions it serves. The company's long-standing history since 1984 underscores its sustained dedication to medical innovation and patient well-being.